Study at a glance
What question did the studies ask?
Researchers asked how vitamin D affects cells with features of senescence. Senescence is a state in which cells stop dividing for a long time but remain active. This review compares laboratory experiments and one small randomized human trial.
What did the researchers find?
Most laboratory studies used calcitriol, the active vitamin D hormone. Some experiments found changes in proteins involved in DNA repair. DNA is the material that carries genetic information. Others found lower release of selected inflammatory substances. Another improved a response to introduced DNA. These changes did not establish that the cells began dividing again or were removed. Other experiments found more senescence-associated features in injured human lung-cancer cells and kidney-cancer cells. Those models differ from healthy human tissue.
The human trial studied 88 older adults with low vitamin D levels. It compared two daily vitamin D3 doses, with or without N-acetylcysteine, for eight weeks. Higher-dose groups had lower selected blood-cell measurements than the lower dose alone. Some other measurements did not show a clear difference between groups. Blood inflammation measures did not show clear differences between groups. A staining result was not a direct count of senescent cells.
What does this mean?
Vitamin D can affect particular cell processes without establishing reversal of senescence. Laboratory hormone treatment, receptor deletion and oral vitamin D3 are different interventions. These studies did not establish that vitamin D clears senescent cells or slows ageing in people.
Read the full article below ↓Vitamin D-related signalling changes several pathways associated with cellular senescence, but the experiments do not support a single universal anti-ageing effect. Depending on the model, calcitriol alters DNA-repair proteins, inflammatory secretions, growth-associated markers or responses to DNA challenge; some injured and malignant cells instead show more senescence-associated features. This review distinguishes those effects from reversal of stable growth arrest or removal of senescent cells. For a shorter account, read Vitamin D and Cellular Senescence Pathways: Study Summary.
What senescence measurements mean
Senescence describes a cell state involving durable withdrawal from division, together with other changes that vary by cell type and trigger. Repeated divisions, oncogene activation, irradiation and chemical injury create different experimental settings. A positive stain or altered gene is not a complete diagnosis on its own. The broader physiology is explained in Vitamin D and Cellular Senescence.
Three intervention claims must be kept separate. Preventing cells from entering senescence requires an appropriate comparison across that transition. Reversal of growth arrest requires evidence that previously arrested cells resume sustained division. A broader claim of senescence reversal also requires appropriate checks of the cell state. Better DNA repair, secretion or challenge responses alone do not establish either claim. Clearing senescent cells requires showing their selective removal. A fourth possibility is changing what surviving cells secrete. That may matter biologically without demonstrating any of the first three claims. A lower inflammatory signal cannot stand in for all of them. [1] [2] [3] [5]
This focused evidence review compares primary experiments rather than pooling unlike endpoints. Cultures, repeated measurements and animal arms within a paper are not independent studies. Most laboratory interventions used calcitriol, the active vitamin D hormone, whereas the small randomized human trial used oral cholecalciferol, or vitamin D3. Neither exposure is equivalent to deleting the vitamin D receptor, abbreviated VDR. Receptor biology is introduced in Vitamin D Receptors. The research doses below describe experiments and do not provide personal treatment advice.
Replicative ageing in human stromal cultures
Klotz and colleagues followed human marrow-derived mesenchymal stromal cells through serial passages, repeatedly transferring cells into fresh culture vessels. The overall programme involved 11 femoral-head donors, but individual assays used smaller subsets. Calcitriol at 100 nanomoles per litre slowed proliferation and changed selected morphology and senescence-associated measurements. The cells also retained the ability to undergo induced cartilage, fat and bone differentiation. This separates retained developmental potential from spontaneous commitment, a distinction developed in Vitamin D and Cell Differentiation. [1]
The title describes delayed cellular ageing, but the most defensible interpretation remains narrower than rejuvenation. Pooled cumulative population doublings did not significantly differ between treatment groups. Comparisons at the same passage can involve different elapsed times and division histories when treatment itself slows growth. Donor attrition and small assay-specific samples add uncertainty. Thus, changed late-passage markers do not establish an extended replicative lifespan or restored tissue function. [1]
The experiment also challenges a simple antioxidant explanation: reactive oxygen species increased at an early passage rather than falling uniformly. Reactive oxygen species are chemically reactive molecules that can contribute to both signalling and injury. The broader balance is discussed in Vitamin D and Oxidative Stress. The result does not identify one universal oxidative mechanism for vitamin D effects on senescence. [1]
Oncogene-induced arrest: DNA-repair proteins can improve without reversal
Graziano and colleagues activated an oncogenic form of Ras in fibroblast models, including telomerase-expressing cells. They measured VDR, BRCA1 and 53BP1, proteins involved in the response to DNA damage, and used gene silencing and repair-related assays. Ras activation lowered parts of this repair programme. Calcitriol at 100 nanomoles per litre restored selected repair-factor abundance or recruitment, but did not prevent the oncogene-induced senescent arrest. [2]
That negative result determines the interpretation. Repair-factor recovery and release from growth arrest are different outcomes. A DNA-damage focus is a local concentration of repair-associated proteins, not a direct measurement of cancer prevention or younger tissue. The repair pattern also differed after other senescence-inducing insults. The findings therefore identify one context-dependent regulatory response, rather than a treatment that reverses all forms of senescence. Changes in transcription and protein abundance must be evaluated separately, as described in Vitamin D and Gene Expression. [2]
Established senescent fibroblasts: changing secretion
Sayegh and colleagues used primary skin fibroblasts that had been irradiated and then maintained for 14 days to establish a senescent state. They subsequently treated the cells with 10 nanomoles per litre calcitriol for 24 hours or seven days. Secretion of selected inflammatory mediators, including CCL2, interleukin-6 and interleukin-8, decreased, alongside a partial reduction in p38 signalling. The cytokine work included seven donors; repeated protein experiments are not additional donors. [3]
The senescence-associated secretory phenotype is the mixture of substances released by these cells. Changing that mixture could influence neighbouring cells and local immune responses. It does not show selective killing, resumed division or reversal of the original arrest. A limited washout observation in supplementary material is also insufficient to establish a general long-lasting effect. This distinction matters when connecting cell signalling with Vitamin D and Regeneration: renewal requires more than a reduction in one group of secreted molecules. [3]
The paper also reanalysed samples from an older-adult skin-challenge cohort, which is considered separately in the tissue-outcome review. It is not an independent new clinical trial. Despite the paper title using vitamin D3, the direct fibroblast intervention was calcitriol. Its human cohort used oral cholecalciferol. These forms must not be merged into one exposure. [3]
Contrary evidence in injured lung models
Guijarro and colleagues tested calcitriol in bleomycin-injured A549 cells, a lung-cancer-derived model, and in mouse lung injury. At five nanomoles per litre, calcitriol increased selected persistent damage and senescence-associated measures in the injured A549 cells. The added effect was not reproduced simply by calcitriol alone or by every injury condition, and lung myofibroblasts behaved differently. The study therefore supplies a material opposite direction, not proof of a universal pro-senescence action. [4]
The accompanying mouse findings included worse fibrosis and weight loss. These endpoints raise a tissue-level concern within that model, but are not a human trial of ordinary oral vitamin D3. The paper gives inconsistent bleomycin doses between sections, so an exact injury-dose comparison cannot be securely reconstructed here. Its statements about reactive oxygen species also do not support treating one oxidative route as an established mediator. The reliable point is cell: and insult-dependent worsening under the studied conditions. [4]
Malignant kidney cells: more senescence-associated features
Shen and colleagues exposed 786-O kidney-cancer cells to 100 nanomoles per litre calcitriol for 48 hours. They reported more JMJD3, an enzyme involved in removing methyl groups from histones, together with lower global H3K27me3, increased p16 and more senescence-associated beta-galactosidase staining. Reducing JMJD3 with small interfering RNA attenuated parts of the response. These experiments connect a proposed histone-related pathway to the observed cellular phenotype. The broader distinction between histone marks and gene activity is covered in Vitamin D and Epigenetic Regulation. [5]
However, the study did not establish stable irreversible arrest through a convincing withdrawal and recovery test. It did not isolate a particular gene-locus methylation change through epigenetic editing, and it did not directly perturb VDR to establish that step. Histone normalization and figure-label inconsistencies further limit fine interpretation. More senescence-associated features in a malignant cell can be investigated as a tumour-suppressive idea, but this paper does not establish clinical cancer treatment or an equivalent effect in healthy ageing tissue. [5]
DNA sensing: restoring a challenge response is a different endpoint
Cancado and colleagues examined late-passage, irradiated and progeria-related fibroblast models. Progeria is a rare premature-ageing disorder and does not reproduce every aspect of normal ageing. Seven days of 100 nanomoles per litre calcitriol improved selected responses to introduced DNA, including production of the messenger cGAMP and downstream STING signalling. These are components of a DNA-sensing defence pathway. The work tests responsiveness to a challenge, rather than merely asking whether an unstimulated inflammatory marker falls. [6]
A stronger response to introduced DNA is not evidence that senescent cells were cleared or that older people became more resistant to infection. The paper also contains a mouse lifespan experiment with H-151, a separate STING inhibitor. That lifespan extension must not be attributed to vitamin D. This study and the oncogene-repair paper come from the same broader research programme; their distinct experiments are complementary, not independent laboratory replications of one universal effect. [6] [2]
A skeletal pathway involving cell-cycle control
Xu and colleagues investigated active-hormone insufficiency in Cyp27b1-heterozygous mice and stress responses in cultured human marrow stromal cells. CYP27B1 helps generate active vitamin D. Their experiments connected VDR-dependent CDK2 transcription to P27 degradation, including promoter-binding and reporter tests, protein regulation and genetic P27 deletion. CDK2 and P27 participate in control of cell division. The data provide a more developed causal chain than a marker association alone. [7]
Nevertheless, deleting P27 is not vitamin D treatment and is not selective removal of senescent cells. Partial skeletal rescue in a global genetic model does not establish a safe anti-ageing intervention. The human cell experiments used oxidative stress and early-passage cultures, rather than proving reversal of ordinary long-term replicative ageing. The studies connect a regulatory pathway to selected cellular and skeletal phenotypes while leaving normal-human ageing and treatment efficacy unresolved. [7]
A small randomized human marker study
Rastgoo and colleagues randomized 88 older adults selected for vitamin D blood levels below 30 nanograms per millilitre into four groups for eight weeks. This was the study eligibility threshold, not a universal clinical definition of deficiency. The groups received 1,000 or 5,000 international units of vitamin D3 daily, with or without 600 milligrams of N-acetylcysteine. This was an active-dose comparison, not a placebo-controlled test of supplementation versus none; there was no N-acetylcysteine-only group. A formal correction establishes 5,000, rather than 50,000, international units in affected table labels. [8] [9]
The authors reported lower beta-galactosidase green area and selected p16 and inflammatory-gene measurements in the 5,000-unit groups compared with 1,000 units of vitamin D3 alone. These were measurements in peripheral blood mononuclear cells, a mixed group of immune cells. That comparison does not by itself show that adding N-acetylcysteine is better than 5,000 units alone. The beta-galactosidase assay measured green-stained pixel area, not a validated percentage of senescent immune cells. p21 expression did not significantly improve. Between-group differences in circulating interleukin-6, C-reactive protein and the neutrophil-to-lymphocyte ratio were not significant. An internal discrepancy in reported p16 numbers prevents a reliable precise fold-change claim. [8]
Randomization makes this a useful human contribution, but the small groups and short duration do not establish clearance of senescent cells, reversal of immune ageing or improved clinical resilience. Cell mixture and assay interpretation remain important. The null serum results must accompany the selected positive cellular signals, rather than being replaced by the broader claim that inflammation was reduced throughout the body. [8]
Comparing the actual scientific claims
| Experiment | Supported finding | Claim not established |
|---|---|---|
| Serial-passage stromal cells | Selected markers changed with slower proliferation | Extended replicative lifespan or rejuvenated tissue |
| Oncogene-induced fibroblasts | Repair-factor response improved | Prevention or reversal of the arrest |
| Established senescent skin fibroblasts | Selected inflammatory secretions decreased | Selective clearance or renewed division |
| Lung-injury and kidney-cancer models | Some senescence-associated features increased | A common effect in all healthy cells |
| DNA-challenge fibroblasts | Selected DNA-sensing responses improved | Clinical antiviral protection or vitamin D lifespan extension |
| Randomized older-adult trial | Selected blood-cell measures differed by active regimen | A proven fall in whole-body senescent-cell burden |
The evidence supports modulation of particular senescence-related processes. It does not support using “anti-senescence” as a synonym for clearance, renewed division or slower ageing. Different triggers, cell states and endpoints explain why opposing results can be scientifically informative without cancelling each other or proving one universal mechanism. Translation to Vitamin D and Age-Related Decline requires actual tissue and human outcomes, rather than extending cellular language beyond what was measured.
Scientific sources
[1] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.
[2] Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Oncogene. 2016;35(41):5362-5376. DOI 10.1038/onc.2016.77; PMID 27041576; PMCID PMC5050051.
[3] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.
[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.
[5] Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation. Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget. 2017;8(59):100187-100195. DOI 10.18632/oncotarget.22124; PMID 29245970; PMCID PMC5725012.
[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging. Cancado de Faria R, Silva LND, Teodoro-Castro B, McCommis KS, Shashkova EV, Gonzalo S. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(28):e2424666122. DOI 10.1073/pnas.2424666122; PMID 40638086; PMCID PMC12280946.
[7] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.
[8] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.
[9] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.
Related reading
1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC).
Original paper ↗Read more →Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation
In this study, the biological effect and epigenetic regulation of calcitriol on kidney cancer cells were investigated.
Original paper ↗Read more →Detrimental pro-senescence effects of vitamin D on lung fibrosis
The multiple biological effects of vitamin D and its novel activities on inflammation and redox homeostasis have raised high expectations on its use as a therapeutic agent for multiple fibrogenic conditions.
Original paper ↗Read more →Unveiling the Metabolic Trajectory of Pig Feces Across Different Ages and Senescence
The objective was to elucidate age-associated changes in metabolite composition and functionality under standardized rearing conditions.
Original paper ↗Read more →Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing
Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.
Original paper ↗Read more →Vitamin D and Cellular Senescence Pathways: Study Summary
What cell studies show about vitamin D and senescence pathways, with clear distinctions between changed markers, less inflammation and reversal of ageing.
Read more →Vitamin D, Cellular Senescence and Chronic Kidney Diseases: What Is Missing in the Equation?
As life expectancy increases in many countries, the prevalence of age-related diseases also rises.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults
Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups.
Original paper ↗Read more →Vitamin D and Cellular Senescence
Explains the relationship between vitamin D and cellular senescence, including gene regulation, mitochondrial function, oxidative stress, and inflammatory signalling, and how these processes relate to ageing cells.
Read more →1,25-Dihydroxyvitamin D Deficiency Accelerates Aging-related Osteoarthritis via Downregulation of Sirt1 in Mice
Emerging observational data suggest that vitamin D deficiency is associated with the onset and progression of knee osteoarthritis (OA).
Original paper ↗Read more →Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms.
Original paper ↗Read more →Low-dose oral cholecalciferol is associated with higher numbers of Helios+ and total Tregs than oral calcitriol in renal allograft recipients: an observational study
We evaluated whether there was a difference in the absolute numbers of Helios+, Helios−, CTLA-4+, IFNg+, and total Tregs among the patient groups.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Calcitriol enhances Doxorubicin‐induced apoptosis in papillary thyroid carcinoma cells via regulating VDR/PTPN2/p‐STAT3 pathway
The primary aim of this study was to investigate the role of Calcitriol on papillary thyroid carcinoma (PTC) and explore the possible mechanism.
Original paper ↗Read more →Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway
Environmental factors, including westernised diets and alterations to the gut microbiota, are considered risk factors for inflammatory bowel diseases (IBD).
Original paper ↗Read more →Calcitriol Supplementation Causes Decreases in Tumorigenic Proteins and Different Proteomic and Metabolomic Signatures in Right versus Left-Sided Colon Cancer
Vitamin D deficiency is a common problem worldwide.
Original paper ↗Read more →Effects of personalized vitamin D3 on inflammation in colorectal cancer patients: a randomized trial
In an ongoing randomized double-blind, placebo-controlled trial in Germany, CRC patients who underwent surgery in the past year and had serum 25-hydroxyvitamin D levels.
Original paper ↗Read more →Mechanistic Effects of Calcitriol in Cancer Biology
In the context of cancer, calcitriol regulates the cell cycle, induces apoptosis, promotes cell differentiation and acts as anti-inflammatory factor within the tumor microenvironment.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels in Breast Cancer Risk in Mali: A Case-Control Study
The aim of the current study was to determine the association between metabolites circulating in the blood, 25(OH)D and 1,25(OH)2D, and vitamin D levels with the risk of breast cancer in Malian women.
Original paper ↗Read more →Regulation of HHLA2 expression in kidney cancer and myeloid cells
HHLA2 expression in A498 and 786-O ccRCC cell lines was examined in vitro and in subcutaneous tumor xenografts in NSG mice.
Original paper ↗Read more →Original sources
1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC).
Publication details
[1] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.
Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.
Published in Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Oncogene (2016).
Publication details
[2] Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Oncogene. 2016;35(41):5362-5376. DOI 10.1038/onc.2016.77; PMID 27041576; PMCID PMC5050051.
Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing
Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.
Publication details
[3] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.
Detrimental pro-senescence effects of vitamin D on lung fibrosis
The multiple biological effects of vitamin D and its novel activities on inflammation and redox homeostasis have raised high expectations on its use as a therapeutic agent for multiple fibrogenic conditions.
Publication details
[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.
Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation.
Published in Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget (2017).
Publication details
[5] Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation. Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget. 2017;8(59):100187-100195. DOI 10.18632/oncotarget.22124; PMID 29245970; PMCID PMC5725012.
A noncanonical cGAS-STING pathway drives cellular and organismal aging.
[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging.
Publication details
[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging. Cancado de Faria R, Silva LND, Teodoro-Castro B, McCommis KS, Shashkova EV, Gonzalo S. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(28):e2424666122. DOI 10.1073/pnas.2424666122; PMID 40638086; PMCID PMC12280946.
Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation.
Published in Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology (2026).
Publication details
[7] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.
Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial.
Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology (2025).
Publication details
[8] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.
Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial
Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology (2025).
Publication details
[9] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.